GEN-MKT-18-7897-A
Feb 13, 2024 | Blogs, LC, Pharma, QTRAP / Triple Quad, ZenoTOF 7600 system | 0 comments
Read Time: 3 minutes
Managing metabolite identification (Met ID) studies is challenging, so what is at the top of your priority list as you plan the year ahead? Ensuring you have the data needed to manage product safety, meeting deadlines, staff recruitment and training, maintaining compliance, capital expenses, or something else?
At SCIEX, we aim to design solutions that solve these real-world challenges, to make the process more efficient. Imagine the advantages of unambiguous metabolite identification by liquid chromatography-mass spectrometry (LC-MS), even for challenging analytes such as phase II confirmation of glucuronide metabolites.
Manage product safety
Help ensure product safety with complete structural elucidation—even for challenging analytes such as phase II metabolites—with electron activated dissociation (EAD). The ZenoTOF 7600 system can collect EAD and collision-induced dissociation (CID) MS/MS spectra in a single LC-MS/MS experiment.
Meet deadlines
Robust and reliable instruments allow for predictable scheduling and on-time project completion. When needed, our systems are supported by highly respected services and backed by the SCIEX Now support network to ensure that service calls are quickly reported and tracked.
Efficient staff recruitment and training
Streamline new-hire training with knowledge-base articles available on demand from the SCIEX Now Learning Hub. SCIEX OS software is designed to be easy to learn and use for data collection, processing and reporting within a single platform.
Regulatory requirements
SCIEX OS software is compliant-ready to help ease the burden of regulatory activities, including managing user access levels and to reduce the potential for human error.
Capital expense
Invest only in what you need, so you don’t have to spend money on features and system performance that are unnecessary for your samples.
Routine metabolite identification
Larger batches of samples with analytes that typically fragment well using collision-induced dissociation (CID) enable confident identification of the site of metabolism without additional confirmatory testing. In this situation where priorities are typically ease of use and a robust system that does the job day in and day out, SCIEX recommends using the ExionLC AE system coupled to the X500R QTOF system, SCIEX OS software and maintenance with SCIEX service and support.
The workflow described in the technical note Rapid soft spot analysis using a routine biotransformation solution (sciex.com) demonstrates the performance you can expect from this system.
Complex metabolite identification
When clear identification of the site of metabolism is not possible using CID, a secondary analytical technique, such as nuclear magnetic resonance (NMR), is often required to meet regulatory requirements. Since this approach can be both time-consuming and expensive, an LC-MS system with more analytical power is ideal.
The ZenoTOF 7600 system offers electron activated dissociation (EAD) as a complementary fragmentation option to CID. EAD typically fragments the metabolite in different locations, which can provide the additional information required for clear identification of the site of metabolism from a single analytical technique.
SCIEX recommends using the ExionLC AE system coupled to the ZenoTOF 7600 system, SCIEX OS software and maintenance with SCIEX service and support.
The workflow described in the technical note Enhanced drug metabolite identification using collision induced dissociation (CID) and electron-activated dissociation (EAD) (sciex.com) is a useful example of this solution.
Learn more
For more information on the options SCIEX offers for Met ID, please speak to your account manager or visit our web page on Comprehensive Metabolite Identification | SCIEX
Regulated laboratories are evolving faster than ever. New analytical modalities, higher sample throughput, increasing regulatory scrutiny, and leaner teams are reshaping how work gets done. At the same time, expectations for data integrity, standardization, and operational efficiency continue to increase complexity and/or scope. In this environment, LC-MS software is no longer simply an instrument control platform—it has become a critical part of a laboratory’s quality management system. The question is no longer whether your lab has changed, but whether your software has evolved to support the way regulated labs operate today, and if they are ready and able to meet the demands, they will face tomorrow.
Analyst software has long been a trusted foundation in regulated LC-MS laboratories—and for many, it still performs reliably today. But regulated environments are evolving faster than ever. As labs transition to Windows 11, strengthen cybersecurity policies, modernize IT infrastructure, and prepare for future compliance expectations, software decisions are no longer just about what works today—they’re about managing tomorrow’s risk. Analyst will not be supported on Windows 11. While some labs may continue operating in unsupported environments temporarily, the bigger question is: when that risk becomes reality, will your lab be reacting under pressure—or executing a planned mitigation strategy with confidence?
As regulatory scrutiny increases and detection requirements tighten, laboratories are facing a new question: How can TFA be measured reliably, sensitively, and at scale?
Posted by
You must be logged in to post a comment.
Share this post with your network